Sotera Health Company
SHC
17.90
-0.35
-1.92%
Sotera Health Company
US · SHC
#2097 by market cap
Listed 2020
17.90
-0.35
-1.92%
Live - 5344 symbols - heartbeat 369s ago
· 2026-10-08 07:56
Pre-market
18.08
+0.98%
After-hours
17.90
0.00%
- Market cap
- 5.11B
- P/E (TTM)i
- 31.40
- P/Bi
- 7.67
- EPSi
- 0.27
- Div yieldi
- 0.00%
- 52W posi
- 71%
Reader sentiment
Are you bullish or bearish on SHC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 103.11% -0.03pp
- Institutions
- 361 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Hedge Fund54.40%
Mutual Fund43.96%
Individual/Insider2.21%
Public Company1.95%
Sovereign Wealth Fund1.25%
Government Pension Fund0.68%
Private Company0.59%
Insurance Company0.11%
Top holders as of 2026-06-30
Sessa Capital IM, L.P.
9.48% · 27.05M sh
Darsana Capital Partners LP
9.46% · 27.00M sh
BlackRock
8.46% · 24.15M sh
Sculptor Capital Management, Inc.
8.41% · 24.00M sh
Sachem Head Capital Management LP
5.45% · 15.56M sh
Vanguard Capital Management, LLC
4.86% · 13.86M sh
Vanguard Portfolio Management, LLC
4.19% · 11.95M sh
T. Rowe Price Group, Inc.
3.78% · 10.78M sh
AQR Capital Management
3.75% · 10.69M sh
Janus Henderson Group plc
2.94% · 8.40M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 23 buys · 23 sells
| Name | Role | Stake |
|---|---|---|
| Michael Petras | Chairperson & CEO | 1.53% |
| Alton Shader | Chief Executive Officer | 0.20% |
| Alexander Dimitrief | Senior Vice President | 0.10% |
| Michael Rutz | President of Sterigenics | 0.09% |
| Ann Klee | Independent Director | 0.04% |
| Jonathan Lyons | Senior Vice President | 0.04% |
| Sean Cunningham | Independent Director | 0.03% |
| James Neary | Independent Director | 0.03% |
| Vincent Petrella | Independent Director | 0.03% |
| Ruoxi Chen | Independent Director | 0.03% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-16 | Michael Petras | Chairperson & CEO | Open Market Disposition | -1,144,515 | $18.50 |
| 2026-08-06 | Michael Rutz | President of Sterigenics | Open Market Disposition | -150,000 | $18.84 |
| 2026-08-04 | Jonathan Lyons | Senior Vice President | Sale to Issuer | -11,316 | $17.98 |
| 2026-05-25 | Alton Shader | Chief Executive Officer | Other Acquisition | +579,573 | -- |
| 2026-05-25 | Alton Shader | Chief Executive Officer | Other Derivative Acquisition | +101,817 | -- |
| 2026-05-21 | James Neary | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-21 | Sean Cunningham | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-21 | Vincent Petrella | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-21 | Christopher Simon | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-21 | Ann Klee | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-21 | Ruoxi Chen | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-21 | David Wheadon | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-21 | Richard Kyle | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-21 | Karen Flynn | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-21 | Kenneth Krause | Independent Director | Other Acquisition | +14,970 | -- |
| 2026-05-12 | Warburg Pincus LLC | -- | Private Disposition | -19,102,952 | $15.17 |
| 2026-05-12 | GTCR LLC | -- | Private Disposition | -12,654,291 | $15.17 |
| 2026-03-31 | Erika Ostrowski | Vice President, Deputy General Counsel & Corporate Secretary | Initial Statement of Beneficial | 0 | -- |
| 2026-03-30 | Alexander Dimitrief | Senior Vice President | Sale to Issuer | -7,941 | $14.34 |
| 2026-03-01 | Alexander Dimitrief | Senior Vice President | Sale to Issuer | -14,744 | $15.91 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:56:41 · For reference only, not investment advice and not tailored to your situation.